(Q38897136)

7 September 2017

Chemical stability of artesunate injection and proposal for its administration by intravenous infusion (English)

1 reference

7 September 2017

0 references

Batty KT

1

1 reference

7 September 2017

Ilett KF

series ordinal

2

1 reference

7 September 2017

Davis T

series ordinal

3

1 reference

7 September 2017

Davis ME

series ordinal

4

1 reference

7 September 2017

1 January 1996

1 reference

Journal of Pharmacy and Pharmacology

7 September 2017

1 reference

7 September 2017

48

1 reference

7 September 2017

1

1 reference

7 September 2017

22-26

1 reference

The effect of artemisinine, its derivatives and mefloquine against chloroquine-resistant strains of Plasmodium falciparum in vitro

7 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Neurotoxicity in animals due to arteether and artemether.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Interspecies scaling and comparisons in drug development and toxicokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Clinical trials of artemisinin and its derivatives in the treatment of malaria in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Overview of clinical studies on artemisinin derivatives in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute, uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Neurotoxicity of artemisinin analogs in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Antimalarial pharmacokinetics and treatment regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Artemisinin: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

Pharmacology and parasitology: integrating experimental methods and approaches to falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1996.TB05870.X

10.1111/J.2042-7158.1996.TB05870.X

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference